Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2
出版年份 2021 全文链接
标题
Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-23
DOI
10.1038/s41388-021-02015-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
- (2021) Yanlin Ren et al. Cell Death Discovery
- Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer
- (2021) Xiaolin Sang et al. CANCER LETTERS
- Sleep, Growth, and Puberty After Two Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder
- (2020) Beth A. Malow et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway
- (2020) Jian Zhang et al. Aging-US
- The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
- (2020) Jinrui Zhang et al. CELL DEATH AND DIFFERENTIATION
- HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
- (2020) Bob T. Li et al. Cancer Discovery
- MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
- (2019) Jingyan Yi et al. EBioMedicine
- Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer
- (2019) Min Wang et al. Redox Biology
- Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
- (2019) Balasunder R. Dodda et al. Frontiers in Oncology
- Proteasome Inhibitors Suppress ErbB Family Expression through HSP90-Mediated Lysosomal Degradation
- (2019) Thanh Kieu Huynh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors
- (2019) Maxim Shevtsov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Distinct apoptotic blocks mediate resistance to panHER inhibitors in HER2+ breast cancer cells
- (2018) Bahriye Karakas et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Melatonin and Cancer Hallmarks
- (2018) Wamidh Talib MOLECULES
- Melatonin: A Versatile Protector against Oxidative DNA Damage
- (2018) Annia Galano et al. MOLECULES
- Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial
- (2018) Tracey L. Sletten et al. PLOS MEDICINE
- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- (2018) David M. Hyman et al. NATURE
- Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα
- (2018) Jinlei Ding et al. CANCER LETTERS
- HER2-positive breast cancer is lost in translation: time for patient-centered research
- (2017) Isabelle Gingras et al. Nature Reviews Clinical Oncology
- Melatonin for the prevention and treatment of cancer
- (2017) Ya Li et al. Oncotarget
- Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System
- (2017) Stephen T. Hallett et al. Cell Reports
- Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells
- (2016) Yingqiu Zhang et al. CANCER LETTERS
- Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression
- (2016) L. Mao et al. MOLECULAR CANCER RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou–Talalay Method—Letter
- (2015) John C. Ashton CANCER RESEARCH
- The Safety of Melatonin in Humans
- (2015) Lars Peter Holst Andersen et al. CLINICAL DRUG INVESTIGATION
- Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation
- (2015) Roberto Pariente et al. JOURNAL OF PINEAL RESEARCH
- STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
- (2013) SEYUNG S. CHUNG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Governance of Endocytic Trafficking and Signaling by Reversible Ubiquitylation
- (2012) Michael J. Clague et al. DEVELOPMENTAL CELL
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- ErbB2 Trafficking and Degradation Associated with K48 and K63 Polyubiquitination
- (2010) Corina Marx et al. CANCER RESEARCH
- Ubiquitin: Same Molecule, Different Degradation Pathways
- (2010) Michael J. Clague et al. CELL
- Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- The Development of HKI‐272 and Related Compounds for the Treatment of Cancer
- (2008) Allan Wissner et al. ARCHIV DER PHARMAZIE
- Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
- (2008) Marissa V. Powers et al. CANCER CELL
- Geldanamycin-Induced Down-Regulation of ErbB2 from the Plasma Membrane Is Clathrin Dependent but Proteasomal Activity Independent
- (2008) N. M. Pedersen et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation